# Drug-drug Interaction Study Between UIC201601 and UIC201602

> **NCT05190133** · PHASE1 · COMPLETED · sponsor: **Korea United Pharm. Inc.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** UIC201602 and co-administration of UIC201601 and UIC201602
- **DRUG:** UIC201601 and co-administration of UIC201601 and UIC201602

## Key facts

- **NCT ID:** NCT05190133
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-28
- **Primary completion:** 2016-08-17
- **Final completion:** 2016-08-17
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05190133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05190133, "Drug-drug Interaction Study Between UIC201601 and UIC201602". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05190133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*